|
Recent Material Events for ELITE PHARMACEUTICALS INC /NV/
|
| Date |
Description |
|
Jan 03, 2013
|
On December 31, 2012, Ram Potti resigned from the board of directors
of Elite Pharmaceuticals, Inc. citing personal reasons. In his resignation, Mr. Potti expressed that he remains committed in his
support of Elite as he was while a director of the c
|
|
Dec 13, 2012
|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Dec 13, 2012
|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Dec 10, 2012
|
On December 5, 2012 (the “Effective
Date”), Elite Pharmaceuticals, Inc. (the “Company”) amended its bridge loan agreement (the “Loan Agreement”)
with Jerry Treppel, the Company’s Chairman and CEO pursuant to
|
|
Dec 10, 2012
|
On December 5, 2012 (the “Effective
Date”), Elite Pharmaceuticals, Inc. (the “Company”) amended its bridge loan agreement (the “Loan Agreement”)
with Jerry Treppel, the Company’s Chairman and CEO pursuant to
|
|
Nov 15, 2012
|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Nov 15, 2012
|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Oct 15, 2012
|
On October 15, 2012, the Company issued
a press release informing investors that Elite received approval as of September 28th from the U.S. Food and Drug Administration
for generic phentermine capsules 15 mg and 30 mg. Elite also announced that the s
|
|
Oct 15, 2012
|
On October 15, 2012, the Company issued
a press release informing investors that Elite received approval as of September 28th from the U.S. Food and Drug Administration
for generic phentermine capsules 15 mg and 30 mg. Elite also announced that the s
|
|
Aug 14, 2012
|
On August 14, 2012 the Registrant issued a press release, a
copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
|
